STAT News

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals at its facility. It also included photos.

作者 STAT News

8 September 20261 分钟阅读

Health Tech

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

← 返回 IE News

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

相关洞察

Future Supply Chains, Logistics & Fleets
The Supply Chain That Thinks - How AI agents, quantum computing, cheap energy and programmable risk could reshape global logistics, 2026–2036
9 Sept 202619 min read
Synthetic biology and bioengineering
The Bio Revolution Is Here — And the World Is Already Choosing Sides
Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.
8 Sept 202615 min read
Quantum computing
The race to master quantum computing could reshape medicine, energy and security.
8 Sept 202623 min read

Browse all insights →

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

更多Health Tech相关内容

Disabled workers at greater risk of losing health insurance

STAT+: Inhibrx claims first win for long-sought immunotherapy target

STAT+: FDA takes another look at botanical drugs

STAT+: Health care features prominently in Democrats’ agenda

An administrative gap delays access to new pancreatic cancer treatment

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

相关洞察

Future Supply Chains, Logistics & Fleets

The Bio Revolution Is Here — And the World Is Already Choosing Sides

The race to master quantum computing could reshape medicine, energy and security.

STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

更多Health Tech相关内容

Disabled workers at greater risk of losing health insurance

STAT+: Inhibrx claims first win for long-sought immunotherapy target

STAT+: FDA takes another look at botanical drugs

STAT+: Health care features prominently in Democrats’ agenda

An administrative gap delays access to new pancreatic cancer treatment

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

相关洞察

Future Supply Chains, Logistics & Fleets

The Bio Revolution Is Here — And the World Is Already Choosing Sides

The race to master quantum computing could reshape medicine, energy and security.